OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$23.32
0.17 (0.73%)
▲
5d:
+9.43%
30d:
+49.2%
90d:
+73.77%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 9.0/10
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
11 traders called OSCR this week
93% bullish • 1 bearish
93% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: OSCR is 11.6% above its trading range ($20.90). Market expects 15.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: OSCR is 11.6% above its trading range ($20.90). Market expects 15.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$29.83
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$18.52
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $23.32, which is considered extended relative to its 30-day fair value range of $14.69 to $20.90. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.9) compared to its historical average (11.1). At these levels, the market is pricing in 15.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a uptrend. Immediate support is located at $17.80, while resistance sits at $24.28.
Market Sentiment: OSCR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $20.30. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSCR is in a uptrend. Immediate support is located at $17.80, while resistance sits at $24.28.
Market Sentiment: OSCR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $20.30. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.69 -
$20.90
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
42.9%
Protect Your Profits
OSCR is technically overbought (RSI 82). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 13.0% above Wall St target ($20.30)
- NEUTRAL: PE elevated vs history but 15.2% growth expectation is conservative given 126% recent growth
Trading Range Analysis
30-Day Trading Range
$14.69 -
$20.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.81
Resistance Level
$24.28
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.90
Wall Street Target
$20.30
(-13.0%)
Revenue Growth (YoY)
52.6%
Earnings Growth (YoY)
125.6%
Profit Margin
-0.3%
Valuation Premium vs History
+15.2% premium
PE vs Historical
16.9 vs 11.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+15.2%
(market-implied from PE analysis)
1-Year Target
$26.86
(+15%)
2-Year Target
$30.95
(+33%)
3-Year Target
$35.65
(+53%)
3-Yr Target (if PE normalizes)
(PE: 17→11)
PE COMPRESSION
$23.42
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 42.6%)
$88.30
(+279%)
Base:
(SPY PE: 16.9, Growth: 42.6%)
$67.61
(+190%)
Bear:
(PE: 11.1, Growth: 42.6%)
$44.41
(+90%)
Share & Embed Analysis
Last updated: May 16, 2026 12:51 AM ET
Data refreshes hourly during market hours. Next update: 1:51 AM
Data refreshes hourly during market hours. Next update: 1:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Mario Schlosser
SELL
23038 shares
2026-01-08
Mario Schlosser
SELL
76962 shares
2026-01-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$100 | 58 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$387 | 62 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 65 BUY |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$389 | 57 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$244 | 57 HOLD |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
